Navigate Up
Sign In

Delivering HIV/AIDS Treatment in Kenya

To increase access to antiretroviral therapy, the Kenya Pharma project established and operated a sustainable pharmaceutical system to procure, store, and distribute drugs, supplies, and equipment for the care and treatment of people with HIV/AIDS.

Kenya was hit hard by the HIV/AIDS epidemic, with an HIV prevalence rate of about 6 percent. In support the Kenyan government’s efforts to fight HIV/AIDS, Pharma established a pharmaceutical supply chain management system that improved forecasting and planning commodity procurement needs, reduced costs, increases local resources for quality assurance, and ensured that supplies reach remote areas.

The USAID-funded project played a major role in U.S. government efforts to scale-up its provision of the drugs, supplies, and equipment needed for HIV/AIDS care and treatment in Kenya. Through Pharma, Chemonics delivered drugs, supplies, and equipment to HIV/AIDS programs funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). To increase efficiency and transparency, Chemonics also created a web-based information system that provides time and cost savings for the project and the larger PEPFAR initiative. 

Project Results:

  • Zero stockouts in the last four years of Kenya Pharma (46.2 percent of service delivery points experienced stockout in the year before the project began)
  • 416,711 people living with HIV/AIDS treated with anti-retrovirals (ARVs)
  • 832,488 people living with HIV/AIDS treated for opportunistic infections
  • 32,269 pregnant women treated to prevent mother-to-child transmission
  • 26,066 infants treated to limit mother-to-child transmission

Final Report

Project Duration: 2009 - 2015


© Chemonics International Inc.  |  Privacy Policy